Trials / Completed
CompletedNCT00872560
Comparison of 2 NovoFine® Needles on the Reflux of Insulin
Insulin Leakage and Pain Perception in IDDM Children or Adolescents, Where the Injections Are Performed With NovoFine™ 6 x 0.30 mm Needles and NovoFine® 8 x 0.30 mm Needles: An Open, Randomized, Two-period Cross-over, Multi-centre, Phase IIIb Trial at 4 Centres
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and NovoFine® 8 x 0.30 mm on reflux of insulin back to the surface of cutis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovoFine® needle 6 mm | |
| DEVICE | NovoFine® needle 8 mm |
Timeline
- Start date
- 1998-01-20
- Primary completion
- 1998-07-27
- Completion
- 1998-07-27
- First posted
- 2009-03-31
- Last updated
- 2018-08-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00872560. Inclusion in this directory is not an endorsement.